Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Up

Enlarge this image

Until now, children under 16 have not been included in any of the U.S. COVID-19 vaccine trials.

SDI Productions/Getty Images


hide caption

toggle caption

SDI Productions/Getty Images


Coronavirus Live Updates
The Majority Of Children Who Die From COVID-19 Are Children Of Color

Given that children have been greatly affected by the pandemic it is unethical, «to allow children to take on great burdens during this pandemic but not have the opportunity to benefit from a vaccine, or to delay that benefit for an extended period of time, because they have not been included in vaccine trials,» Goza wrote.

In an updated statement on its website, Pfizer outlined the change to include children. Last month, the company said it would expand its trial to include teenagers 16 and older. Now, the company says it has received permission from the FDA to enroll children aged 12 and older. «By doing so, we will be able to better understand the potential safety and efficacy of the vaccine in individuals from more ages and backgrounds,» the statement says.

Pediatricians and infectious disease experts say it made sense to start the vaccine trials with older participants who have a higher risk of more serious illness from COVID-19.

«Children have not been the main focus at this point because of the rush to get these trials going in adults,» says infectious disease expert Yvonne Maldonado, a professor of pediatrics, epidemiology and population health at Stanford University, who chairs the AAP committee on infectious diseases.

She is among the pediatricians who wrote to the FDA in favor of including children in trials. «For almost any other vaccine trial, you’re almost always going to start in adults anyway to find if there’s a safety signal in the adult population before you move into the pediatric population,» Maldonado explains. And, since COVID-19 vaccine development is moving so quickly, pediatricians’ hope has been that children wouldn’t be left behind. «With all of the proper precautions in place and sufficient safety data from adult studies, progressing to trials in older children would be important,» she says.

L.J. Tan says he hopes other pharmaceutical companies that have COVID-19 vaccine trials underway will follow suit. «I would hope that the other vaccine manufacturers with covid-19 vaccines, would follow Pfizer’s example and go down to [age] 12,» Tan says.

  • COVID-19 vaccine
  • coronavirus vaccine

admin

Добавить комментарий